Re: erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

D A Cameron, R C Leonard

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)728-9
Number of pages2
JournalJNCI: Journal of the National Cancer Institute
Volume91
Issue number8
Publication statusPublished - 21 Apr 1999

Keywords

  • Antibiotics, Antineoplastic
  • Bias (Epidemiology)
  • Breast Neoplasms
  • Chemotherapy, Adjuvant
  • Disease-Free Survival
  • Doxorubicin
  • Drug Administration Schedule
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Lymphatic Metastasis
  • Receptor, erbB-2
  • Survival Analysis
  • Treatment Outcome
  • Tumor Suppressor Protein p53

Cite this